Guardant Health Files 2024 10-K
Ticker: GH · Form: 10-K · Filed: Feb 20, 2025 · CIK: 1576280
| Field | Detail |
|---|---|
| Company | Guardant Health, Inc. (GH) |
| Form Type | 10-K |
| Filed Date | Feb 20, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, financials
TL;DR
Guardant Health dropped its 2024 10-K. Full financials for FY24, FY23, FY22 out.
AI Summary
Guardant Health, Inc. filed its 2024 10-K on February 20, 2025, reporting on its fiscal year ending December 31, 2024. The filing details the company's financial performance and business operations. Key figures and operational details for the fiscal years 2024, 2023, and 2022 are presented, including balance sheet information as of December 31st for those years.
Why It Matters
This filing provides investors and the public with a comprehensive overview of Guardant Health's financial health and strategic positioning for the fiscal year 2024, crucial for understanding its market performance and future prospects.
Risk Assessment
Risk Level: medium — The filing is a standard annual report and does not inherently indicate new risks beyond those typically associated with a publicly traded company in the healthcare sector.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K)
- 2023 — Fiscal Year (Comparative reporting period)
- 2022 — Fiscal Year (Comparative reporting period)
Key Players & Entities
- Guardant Health, Inc. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-02-20 (date) — Filing date
- AmirAli Talasaz (person) — Co-Chief Executive Officer and Director
FAQ
What is the primary business of Guardant Health, Inc.?
Guardant Health, Inc. operates in the Medical Laboratories sector, as indicated by its SIC code 8071.
When was the 10-K filing submitted to the SEC?
The 10-K filing was submitted on February 20, 2025.
What fiscal year does this 10-K report cover?
This 10-K report covers the fiscal year ending December 31, 2024.
Who is listed as a key executive officer?
AmirAli Talasaz is listed as Co-Chief Executive Officer and Director.
What are the key dates for financial reporting in this filing?
The filing provides data for the fiscal years ending December 31, 2024, December 31, 2023, and December 31, 2022, as well as balance sheet information for December 31, 2021.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 20, 2025 by AmirAli Talasaz regarding Guardant Health, Inc. (GH).